| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDT | Ordinary Shares | Options Exercise | $3,800,001 | +50,775 | +104% | $74.84 | 99,538 | 31 Aug 2021 | Direct | F1 |
| transaction | MDT | Ordinary Shares | Sale | $6,812,482 | -50,775 | -51% | $134.17 | 48,763 | 31 Aug 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDT | Stock Option (Right to Buy) | Options Exercise | $0 | -50,775 | -100% | $0.000000* | 0 | 31 Aug 2021 | Ordinary Shares | 50,775 | $74.84 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan. |
| F2 | This option becomes exercisable on June 29, 2018, subject to Medtronic's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018. |
| F3 | This date was previously reported incorrectly as 7/28/2024. |